Comparative Study of Constipation Exacerbation by Potassium Binders Using a Loperamide-Induced Constipation Model.

Area of Science:

• Pharmacology
• Gastroenterology
• Nephrology

Background:

• Dialysis patients often require potassium binders like calcium polystyrene sulfonate (CPS) and sodium polystyrene sulfonate (SPS).
• These binders can exacerbate constipation, a common issue in this patient population.
• Identifying a potassium binder with a lower risk of constipation is clinically significant.

Purpose of the Study:

• To compare the constipating effects of CPS and SPS in a rat model.
• To determine which potassium binder is safer concerning gastrointestinal side effects.

Main Methods:

• A loperamide-induced constipation model was established in rats.
• Rats were treated with loperamide hydrochloride alone or in combination with CPS or SPS.
• Defecation parameters including fecal output, water content, and gastrointestinal transit time (GTT) were assessed.

Main Results:

• Calcium polystyrene sulfonate (CPS) significantly prolonged GTT and reduced fecal water content, indicating increased constipation.
• Sodium polystyrene sulfonate (SPS) did not worsen GTT or fecal water content.
• SPS treatment improved the number of fecal pellets and fecal wet weight compared to the loperamide-only group.

Conclusions:

• Sodium polystyrene sulfonate (SPS) is less likely to exacerbate constipation compared to calcium polystyrene sulfonate (CPS).
• Preferential use of SPS over CPS may help manage constipation in hyperkalemic dialysis patients.
• This finding has implications for improving patient compliance and quality of life.